LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0. — FDA record Z-1484-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 7, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0.
Reason
Software has anomalies that have the potential to cause underdose, overdose, or delay in therapy which could lead to serious patient harm or death.
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Quantity
17 units
Agency-reported status
Ongoing
Source record identifier
Z-1484-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityProduct LVP-SW-0004; UDI-DI 00811505030122.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Distribution: CA, CO, ID, MI, NE, NJ, NV, OK, TX, UT, VA, WA, & WI.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 17, 2024
Recall initiation date
Mar 7, 2024
Center classification date
Apr 11, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records